- +44 (0)1865 282 627
Several hundred new neurons are born in the the adult human hippocampus on a daily basis.
The postnatal rodent subventricular zone generates tens of thousands of neurons every day.
We study postnatal and adult mammalian brain stem cells to uncover fundamental developmental mechanisms and disease pathogenesis.
The Szele group is working on translational as well as fundamental developmental neurobiological questions in health and disease.
Our main discovery platform are the two stem cell niches of the brain - the subventricular zone (SVZ) and the dentate gyrus (DG). The SVZ and DG neurogenic niches contain stem cells, transit amplifying progenitors and neuroblasts. They are convenient biological systems to study fundamental developmental questions since one can easily modulate gene expression in them. We investigate the role of the SVZ in models of neurodegeneration and neuropsychiatric disorders. We also study human neurogenesis in postmortem sections and with induced pluripotential stem cells. We are interdisciplinary and have many excellent collaborators.
The neurogenic niches harbour stem cells that attempt to repair brain injury but do so inefficiently. Thus, many of our studies seek to understand how the SVZ and DG respond to disease with the ultimate goal of using molecular insights to augment neurogenesis and enhance progenitor migration towards brain injury. We were the first to show increased neurogenesis after injury and are now partnering with Jan Czernuszka to develop engineered scaffolds for stem cell transplantations. We have focused quite a bit on Galectin-3 (Gal-3) a proinflammatory protein we found is necessary for SVZ neuroblast migration. We showed that Gal-3 is also necessary for angiogenesis after stroke and that it is upregulated in multiple sclerosis (MS). We have recently discovered that Gal-3 regulates Wnt and BMP signalling, thereby controlling postnatal SVZ gliogenesis. With Hiroko Isoda we are testing the neurogenic properties of phytochemicals and nutraceuticals. Together with Angela Russell and Steve Davies we have started OxStem Neuro an innovative new company screening small molecules for their potential to stimulate endogenous stem cells and increase adult neurogenesis.
The Szele group are actively pursuing novel mechanistic insight into epigenetic and lncRNA regulation of neurogenesis. Using floxed Eed and Ezh2 mice, we find that different components of the Polycomb repressive complex 2 regulate distinct neurogenic events. We have shown that the lncRNA Visc-2 is dispensable for SVZ neurogenesis but we are now collaborating with Keith Vance and Xiaohua Shen on two other lncRNAs that have fascinating functions in the SVZ. Several of the genes we study such as Gal-3 and lncRNAs impact tumorigenesis and gliomas can arise from SVZ cancer stem cells. Together with Ian Tomlinson we knocked the human IDH1R132H mutation into the SVZ causing a gliomagenic phenotype. We have shown with Xin Lu that ASSP2 regulates inflammation in the SVZ and are working with Eric O'Neill on tumorigenic signalling pathways.
We also have a longstanding interest in the role of abnormal neurodevelopment in neuropsychiatric disorders. We use an integrated suite of animal models, human post-mortem sections and human induced pluripotential stem cells (iPSC) to study Autism and Schizophrenia. In particular we are studying how mutations in the dysbindin gene functionally interact with inflammation to regulate neurogenesis in a murine gene x environment interaction model, in collaboration with David Greaves. We also demonstrated that the striatum contains fewer interneuron subtypes in patients with autism. In collaboration with Tony James and Sally Cowley we are growing iPSC and olfactory stem cells from subjects with adolescent onset schizophrenia
The Szele lab uses a wide range of in vivo and in vitro techniques including stem cell cultures, migration assays, in vivo electroporation, over expression and knockdown, Cre-lox conditional knockouts, etc. We have used 2-photon time-lapse microscopy in slices to record and quantitatively analyse cell behaviours in the SVZ and are developing in vivo approaches of imaging neurogenesis.
We have weekly lab meetings Tuesdays from 9-10.30 AM. Please email Francis Szele if you would like to join us for one or more of these.
We welcome enquiries for collaboration, postdoctoral fellowships or studentships.
07 October, 2017
24 October, 2017
Congratulations to fiishing DPhil student Martin Ducker who has pitched his cell assay to block infiltration of highly aggressive glioblastoma brain tumour and triumphed in first place with unanimous praise from the panel of expert judges in the "IMAGINE IF! Oxford Accelerator competition.
07 October, 2017, Congratulations to Bin Sun whose paper is accepted by Cerebral Cortex. "Polycomb protein Eed is required for neurogenesis and cortical injury activation in the subventricular zone"
28 August, 2017 We welcome our new Postdoc Dr. Noelia Geribaldi Doldan. Noelia joins us from University of Cadiz and will lead our collaboration with Prof. Hiroko Isoda at University of Tsukuba.
28 August, 2017, Scientific Reports publishes 3D cell printing paper - collaboration with Bayley group, "High-Resolution Patterned Cellular Constructs by Droplet-Based 3D Printing"
27 June, 2017, Brain publishes Istvan Adorjan's paper, "Calretinin interneuron density in the caudate nucleus is lower in autism spectrum disorder"
1 April, 2017 We welcome 4 new rotation students! Abishek Arora, Master's in Neuroscience rotation student (April - August 2017), Victor Lu, Master's in Neuroscience rotation student (April - August 2017), Ben Cheung, undergraduate medical student from Chinese University of Hong Kong (April/May 2017), Thomson Loong, , undergraduate medical student from Chinese University of Hong Kong (April/May 2017)
List of funding bodies
MRC, OxStem, Qatar Foundation
SVZ Neuroblasts immunostained for Dcx, beta III-tubulin and PSA-NCAM